Treatment with PPARγ agonists showed a significant improvement in functional independence measure (FIMTM), indicating that the administration of TZDs drugs improved their functional recovery by the modulation of the neuroinflammatory response following stroke [33]. Here, PPARG is linked to stroke disorder.